| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/29/1998 | CA2588670A1 Vectors for inhibiting hiv and tumor growth |
| 01/29/1998 | CA2261566A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 01/29/1998 | CA2261343A1 Avian polynucleotide vaccine formula |
| 01/29/1998 | CA2260767A1 Fas ligand-like protein, its production and use |
| 01/29/1998 | CA2258872A1 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 01/29/1998 | CA2257524A1 Lipid-binding proteins and their therapeutic and diagnostic use |
| 01/28/1998 | EP0821066A1 Polypeptide of glycosaminoglycan sulfotransferase originating from human and DNA coding for the polypeptide |
| 01/28/1998 | EP0821061A2 Calcitonin gene-related peptide receptor component factor (houdc44) |
| 01/28/1998 | EP0821060A2 Diagnosis and therapy of human malign tumors based on E-cadherin mutations |
| 01/28/1998 | EP0820773A1 Treatment of diabetes with a glucokinase gene |
| 01/28/1998 | EP0820526A1 Coding sequences of the human brca1 gene |
| 01/28/1998 | EP0820515A1 Phospholipase c homolog |
| 01/28/1998 | EP0820511A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 01/28/1998 | EP0820510A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors |
| 01/28/1998 | EP0820469A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 01/28/1998 | EP0820462A1 Cleavage of rna using metal complexes |
| 01/28/1998 | EP0820311A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface |
| 01/28/1998 | EP0820310A1 Method for in vivo regulation of cardiac muscle contractility |
| 01/28/1998 | EP0820309A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 01/28/1998 | CN1171816A CDNA encoding BMP type II receptor |
| 01/28/1998 | CN1171814A Polynucleotide tuberculosis vaccine |
| 01/28/1998 | CN1171743A Novel tumor suppressor gene HIC-1 |
| 01/27/1998 | US5712378 Sugar molecule is substituted with hydrocarbon or substituted hydrocarbon groups, antisense agents |
| 01/27/1998 | US5712136 Adenoviral-mediated cell targeting commanded by the adenovirus penton base protein |
| 01/27/1998 | US5712128 Enzymatic RNA molecules |
| 01/27/1998 | US5712115 Polynucleotide encoding polypeptide with amino acid sequences |
| 01/27/1998 | US5712111 DNA encoding bradykinin B1 receptor |
| 01/22/1998 | WO1998002564A1 Hybrid herpes virus/epstein-barr virus vector |
| 01/22/1998 | WO1998002558A2 Chimeric receptors for jak-stat signal transduction |
| 01/22/1998 | WO1998002553A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation |
| 01/22/1998 | WO1998002549A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences |
| 01/22/1998 | WO1998002548A2 Infectious papillomavirus pseudoviral particles |
| 01/22/1998 | WO1998002546A2 Dna immunization against chlamydia infection |
| 01/22/1998 | WO1998002543A1 Novel vegf-like factors |
| 01/22/1998 | WO1998002541A1 Gamma-heregulin |
| 01/22/1998 | WO1998002539A1 GENES FROM 20q13 AMPLICON AND THEIR USES |
| 01/22/1998 | WO1998002529A1 Highly productive packaging lines |
| 01/22/1998 | WO1998002522A1 Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine |
| 01/22/1998 | WO1998002459A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | WO1998002191A2 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 01/22/1998 | WO1998002190A2 Cationic amphiphile/dna complexes |
| 01/22/1998 | WO1998002178A1 Methods of controlling axonal growth |
| 01/22/1998 | WO1998002170A1 Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene |
| 01/22/1998 | WO1998002150A1 System for genetically treating cardiac conduction disturbances |
| 01/22/1998 | WO1998002144A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | WO1998002040A1 System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 01/22/1998 | WO1996020698A3 Surface-modified nanoparticles and method of making and using same |
| 01/22/1998 | CA2547967A1 System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 01/22/1998 | CA2295500A1 Methods of controlling axonal growth |
| 01/22/1998 | CA2262814A1 Highly productive packaging lines_ |
| 01/22/1998 | CA2260771A1 Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene |
| 01/22/1998 | CA2260738A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | CA2260284A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | CA2260034A1 Cationic amphiphile/dna complexes |
| 01/22/1998 | CA2260029A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 01/22/1998 | CA2259964A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences |
| 01/22/1998 | CA2257822A1 Infectious papillomavirus pseudoviral particles |
| 01/22/1998 | CA2257383A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation |
| 01/21/1998 | EP0819758A2 Cationic vehicle: DNA complexes and their use in gene therapy |
| 01/21/1998 | EP0819177A1 Expression library immunization |
| 01/21/1998 | EP0819172A1 Polynucleotide immunogenic agents |
| 01/21/1998 | EP0819170A1 Retroviral vectors |
| 01/21/1998 | EP0819168A1 Human tumor necrosis factor receptor |
| 01/21/1998 | EP0819167A2 Dna encoding galanin galr2 receptors and uses thereof |
| 01/21/1998 | CN1171113A Mutants of Rb and p53 genes and uses thereof |
| 01/21/1998 | CN1171054A Compound |
| 01/20/1998 | US5710137 Nucleic acids and gene expression for cancer cells |
| 01/20/1998 | US5710136 Inhibition of neovascularization using VEGF-specific oligonucleotides |
| 01/20/1998 | US5710037 Retroviral vector particles |
| 01/20/1998 | US5710035 Human elastase IV |
| 01/20/1998 | US5710024 Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44) |
| 01/20/1998 | US5710022 Nuclear mitotic phosphoprotein |
| 01/20/1998 | US5710001 17q-linked breast and ovarian cancer susceptibility gene |
| 01/20/1998 | US5709999 Germline mutation of human breast and ovarian cancer predisposing gene |
| 01/20/1998 | US5709844 Transgenic mice expressing HPV early region oncogene develop progressive cervico-vaginal neoplasia |
| 01/15/1998 | WO1998001563A2 Adenovirus e4 proteins for inducing cell death |
| 01/15/1998 | WO1998001559A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001549A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | WO1998001547A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 01/15/1998 | WO1998001540A1 Method for producing therapeutic dna |
| 01/15/1998 | WO1998001475A1 Growth factor receptor-binding insulin receptor |
| 01/15/1998 | WO1998001162A2 Gene delivery system |
| 01/15/1998 | WO1998001161A2 Gene therapy delivery system for targeting to endothelia |
| 01/15/1998 | WO1998001160A2 Compositions suitable for delivery of genes to epithelial cells |
| 01/15/1998 | WO1998001159A2 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | WO1998001148A1 Use of papillomavirus e2 protein in treating papillomavirus-infected cells and compositions containing the protein |
| 01/15/1998 | WO1997046673A3 Inhibition of hiv-1 replication by antisense rna expression |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | CA2741501A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 01/15/1998 | CA2260368A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259618A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | CA2258792A1 Method for producing therapeutic dna |
| 01/15/1998 | CA2257563A1 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | CA2257408A1 Compositions suitable for delivery of genes to epithelial cells |
| 01/15/1998 | CA2257300A1 Gene therapy delivery system for targeting to endothelia |
| 01/14/1998 | EP0817864A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa |
| 01/14/1998 | EP0817861A1 Gene transfer into the kidney |
| 01/14/1998 | EP0817860A1 Pseudotyped retroviral particles |